Brain Stimulation Therapies: A Comprehensive Overview of ECT, TMS, VNS, eTNS, and Neurofeedback

Dr. Tracey Marks provides an overview of various brain stimulation and neuromodulation techniques used in psychiatry, including Electroconvulsive Therapy (ECT), Transcranial Magnetic Stimulation (TMS), Vagus Nerve Stimulation (VNS), Trigeminal Nerve Stimulation (eTNS), and Neurofeedback. The episode aims to demystify these often misunderstood treatments, highlighting their mechanisms, applications, and efficacy. A central argument is that these device-based therapies offer viable and often superior alternatives or adjuncts to traditional medication, particularly for treatment-resistant conditions like depression, OCD, and ADHD.

The podcast meticulously distinguishes between these modalities based on their invasiveness, mechanism of action, target conditions, and side effect profiles. ECT, while highly effective (70-80% success rate), is an aggressive treatment involving general anesthesia and inducing controlled seizures, with memory loss as a significant side effect. TMS, a non-invasive magnetic stimulation, targets specific brain regions for depression and OCD with fewer memory issues but a slight seizure risk. VNS involves surgical implantation, making it highly invasive, while eTNS is a non-invasive at-home treatment for ADHD. Neurofeedback stands apart as a biofeedback technique teaching self-regulation of brainwaves, though its validity and standardization are still debated.

Dr. Marks outlines typical treatment protocols, such as ECT's acute and maintenance phases, TMS's daily sessions over several weeks, and eTNS's use during sleep. She emphasizes that many of these treatments, like TMS and VNS, are approved for "treatment-resistant" conditions, suggesting their role after medication failure. For patients considering neurofeedback, she advises asking providers about treatment duration, efficacy, and insurance coverage due to its variable acceptance and cost. The discussion implicitly encourages patients and clinicians to consider these options, especially when conventional pharmacotherapy proves insufficient.

Ultimately, the episode underscores the evolving landscape of mental health treatment, moving beyond solely pharmacological approaches to embrace neurobiological interventions. The emphasis on neuroplasticity as a common mechanism across several treatments (ECT, TMS) highlights a modern understanding of brain function and recovery. The varying levels of FDA approval, from long-standing ECT to recent eTNS, reflect ongoing research and validation processes. The podcast broadens the perspective on managing complex psychiatric conditions, offering hope and practical information about advanced therapeutic tools.

ECT because it's still the best treatment we have, even better than medication.

it looks more like it works through a mechanism of increasing neuroplasticity. That is, it improves the connections between the neurons and may even stimulate neuron growth.

Electroconvulsive therapy works about 70 to 80% of the time. And this is in contrast to 30 to 65% rate of success with antidepressants.

A downside to ECT is because of the anesthesia and the way that your brain is stimulated, you tend to have memory loss for the time just before and just after the procedure.

When we look at the brain using functional imaging studies, we see that the left dorsolateral prefrontal cortex is underactive when someone's depressed. So that's the area of the brain that's stimulated for TMS.

For OCD, the area of the brain targeted is the anterior cingulate cortex. The sessions last about 20 minutes, and you're asked to think about your obsessions just prior to the treatment because thinking about them activates this brain region and produces a better response.

It's not used a whole lot and I think partly because it's very invasive and you have a have a surgical procedure. And it takes a long time to see improvement.

Neurofeedback is a type of biofeedback that uses your brainwave wave activity to teach you to regulate brain functions.

In fact, some researchers question how valid it really is, so it's not a widely accepted treatment.

When things are not widely accepted they tend lack standard protocols.